期刊文献+

重症肺炎支原体肺炎患儿血清C-反应蛋白和降钙素原的变化及其临床意义 被引量:9

Changes of Serum CRP and PCT in Children with Severe Mycoplasma Pneumoniae Pneumonia and Its Clinical Value
原文传递
导出
摘要 目的:探讨重症肺炎支原体肺炎(MPP)患儿血清C-反应蛋白(CRP)和降钙素原(PCT)的含量变化及其临床意义。方法:重症MPP住院患儿28例,在其发热3 d内、3~7 d以及热退后3 d分别检测患儿血清CRP和PCT的含量,同期住院的非感染性疾病患儿28例作为对照组。比较各组CRP和PCT水平。结果:重症MPP患儿在发热3 d内血清CRP和PCT仅轻度增高,而发热超过3 d后血清CRP和PCT含量较前明显增高,与对照组比较差异有统计学意义(P<0.05);当热退后,其含量也恢复正常,与对照组比较差异无统计学意义(P>0.05)。结论:动态监测MPP患儿血清CRP和PCT的变化,能帮助临床尽早准确地判断MPP患儿病情轻重,及时调整治疗方案,从而减少MPP严重并发症的发生。 OBJECTIVE: To probe into the change of serum ClIP and PCT in children with severe mycoplasma pneumoniae pneumonia (MPP) and its clinical significance. METHODS: 28 children with severe MPP were diagnosed and selected from May. 2009 to May. 2010. In the 3 days of fever, 3~7 days of fever and 3 days after reducing fever, the levels of serum CRP and PCT were measured. 28 children inpatients with non-infectious disease were involved in control group. The levels of CRP and PCT were compared. RESULTS: The levels of CRP and PCT in children with severe MPP increased slightly in 3 days of fever. The levels of CRP and PCT increased significantly in children with fever more than 3 days. There were significant differences between observation group and control group (P〈0.05). The levels of CRP and PCT returned to normal after reducing fever (P〉0.05). CONCLUSION: The levels of CRP and RCT which contribute to indentify the severity of MPP and to formulate therapeutic regimen should be monitored. The occurrence of severe complication of MPP can be reduced.
出处 《中国药房》 CAS CSCD 北大核心 2010年第46期4388-4390,共3页 China Pharmacy
关键词 重症肺炎支原体肺炎 C-反应蛋白 降钙素原 儿童 Severe mycoplasma pneumoniae pneumonia C-reactive protein Procalcitonin Children
  • 相关文献

参考文献9

二级参考文献56

共引文献546

同被引文献130

  • 1叶棋浓,苏国富,袁艺,黄翠芬.人单核细胞趋化蛋白-1(MCP-1)基因的PCR扩增、克隆及序列分析[J].中华微生物学和免疫学杂志,1994,14(1):29-32. 被引量:6
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 3韩晓华,刘立云,敬宏,刘铁英,赵永强,尚云晓.小儿肺炎支原体肺炎合并全身炎症反应综合征时炎性相关因素的变化及临床意义[J].中国当代儿科杂志,2007,9(4):347-350. 被引量:42
  • 4Kathleen A,Thurman, Nicholas D, et al. Compariston of labora-tory diagnostic procedures for detection of mycoplasma pneu-moniae in community outbreaks. Clin Infect Dis, 2009,48 ( 9 ) : 1244-1249.
  • 5Jeffery N, Gasser RB. Classification of Myeoplasma synoviae strains using single-strand conformation polymorphism and high-resolution melting-curve analysis of the vlhA gene single-copy region. Micro- biology,2007,153 ( 8 ) : 2679-2688.
  • 6Kannan TR,Baseman JR. ADP-ribosylating and vacuolating eytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Nail Acad Sci USA, 2006,103 ( 17 ) :6724-6729.
  • 7..抗茵药物临床应用指导原则[S]..卫生部,国家中医药管理局,总后卫生部,,2004-8..19..
  • 8Schuetz P, Christ-Crain M, MiJller B. Biomarkers to im- prove diagnostic and prognostic accuracy in systemic in- fections [J]. Curr Opin Crit Care, 2007,13 ( 5 ) : 578.
  • 9Terence C, Frank G.Early diagnosis of sepsis using serum bio- markers [J]. Expert Rev Mol Diagn, 2011,11 (5) : 487.
  • 10Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis [J]. Clin Chest Med, 2008, 29 (4) : 591.

引证文献9

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部